Advisory Board

QB3’s industrial advisory board, which includes both industry and venture capital leaders, provides private sector perspective on QB3’s role in the California economy. The board also places QB3’s work in a national and international perspective, identifying emerging opportunities and needs that might best be met by the institute’s research and education programs and that will enhance the institute’s development and impact. The board also helps define performance expectations and meaningful metrics for the institute.

Board Members

Brian Atwood, Managing Director, Versant Ventures
Remi Barbier, President & CEO, Pain Therapeutics, Inc.
Karen Boezi, CEO, Redwood Bioscience
William K. Bowes, Jr., Founding Partner, U.S. Venture Partners
Brook Byers, Partner, Kleiner Perkins Caufield & Byers
Ronald C. Conway, Founding General Partner, Angel Investors
William Ericson, Managing Partner, Mohr, Davidow Ventures
Luke Evnin, General Partner, MPM Capital
Stephen P.A. Fodor, Founder & Executive Chairman, Affymetrix, Inc.
David V. Goeddel, Managing Partner, The Column Group
Corey S. Goodman, Chairman of the Board, iPierian and Limerick BioPharma
Arthur D. Levinson, Chairman of the Board, Genentech
George Marcus, Chairman, The Marcus & Millichap Company
Joel Marcus, Chairman & CEO, Alexandria Real Estate Equities, Inc.
Lenny Mendonca, Director, McKinsey Global Institute
Jonathan Murray, General Manager, GE Healthcare Technologies
Edward Penhoet, Director, Alta Partners
J. Leighton Read, General Partner, Alloy Ventures
William J. Rutter, Chairman & Chief Executive Officer, Synergenics, LLC
James Sabry, VP, Partnering, Genentech
George Scangos, CEO, Biogen Idec, Inc.
Jack Wadsworth, Advisory Director, Morgan Stanley
Anne Wojcicki, Co-Founder, 23andme